Hospital Angelina Caron Joins Clinerion’s Patient Network


Applied Clinical Trials

Hospital Angelina Caron, of Campina Grande do Sul, Paraná, is the latest Brazilian hospital to join Clinerion’s network of partner hospitals on its Patient Network Explorer platform. Hospital Angelina Caron has nearly one million patients and specializes in cardiology, ophthalmology, pediatrics and neonatology, gynecology and obstetrics, orthopedics, transplants, obesity and digestive system, oncology, neurology, cardiology, nephrology, vascular and endovascular surgery. The hospital has run 10 international trials per year for the past five years.

Clinerion’s Patient Network Explorer helps partner hospitals be visible to pharmaceutical companies seeking suitable patients and sites for their clinical trials. Leveraging patient medical data, queries based on trial protocols may be sent to partner hospitals to assess the count of eligible patients in their electronic health records. All patient data is de-identified and remains under the control of the hospital and inside its IT infrastructure. However, Clinerion’s patented technology also enables authorized trial staff at the hospital to re-identify the patient for the purpose of trial recruitment, while maintaining strict personal data privacy standards.

“With the Clinerion database system, there will be a great progress in research at our center, facilitating patient selection and increasing our effectiveness. Today, a database and facilitating access to information are fundamental to the evolution of research”, says Dalton B. Precoma MD, PhD, cardiologist of Hospital Angelina Caron.

“We are so pleased that our patient coverage in Brazil is expanding by leaps and bounds,” says Ian Rentsch, CEO of Clinerion. “It shows that the benefits of visibility to pharmaceutical trial sponsors that we offer to hospitals running international clinical trials are well understood and accepted.”

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.